European Journal of Breast Health
Case Report

PERIDUCTAL STROMAL SARCOMA

1.

İzmir Atatürk Eğitim ve Araştırma Hastanesi, 4. Genel Cerrahi Kliniği, Izmir, Türkiye

2.

İzmir Atatürk Eğitim ve Araştırma Hastanesi, Patoloji Kliniği, İzmir, Türkiye

Eur J Breast Health 2007; 3: 82-84
Read: 410 Downloads: 190 Published: 24 July 2019

Abstract

Malignant mesenchymal tumours of the breast are rare neoplasms, and their incidence varies from 1%-3% of all malignant breast tumours. Periductal stromal sarcoma of the breast which a rare subgroup of malignant mesenchymal tumours is an extremely uncommon tumour. Excision of tumor with a negative margin is the primary modality in treatment of periductal stromal sarcoma of the breast. The role of radiotherapy and chemotherapy is still controversial in these patients.

We report herein the case of a 52-year-old women in whom a periductal stromal sarcoma of the breast was managed with breast preserving surgery without radiotherapy or chemotherapy. No localy recurrence or metastasis was detected in the patient during sixteen months follow-up.

Files
EISSN 2587-0831